NCT00025272View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 1, 2001

Primary Completion Date

January 18, 2005

Study Completion Date

January 18, 2005

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

DRUG

etoposide

DRUG

topotecan hydrochloride

RADIATION

radiation therapy

Trial Locations (5)

29303

CCOP - Upstate Carolina, Spartanburg

29615

CCOP - Greenville, Greenville

27534-9479

Southeastern Medical Oncology Center, Goldsboro

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

23298-0037

MBCCOP - Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00025272 - Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter